← All indications
Hypercholesterolemia
A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
Drugs by status
Approved for this indication (29)
- simvastatin
- ezetimibe
- lomitapide
- bempedoic acid
- cholestyramine
- clofibrate
- colestipol
- fluvastatin
- probucol
- amlodipine
- pitavastatin
- niacin
- oleic acid
- phytosterol
- atorvastatin
- policosanol
- pravastatin
- acacia
- fenofibrate
- avocado
- lovastatin
- red yeast
- cerivastatin
- triparanol
- dextrothyroxine
- Tafolecimab
- red rice yeast extract
- lerodalcibep
- cannabigerol
Phase 4 trials (35)
- methylprednisolone
- abacavir
- astaxanthin
- barberry
- berberine
- bezafibrate
- colesevelam
- laropiprant
- folic acid
- calcium
- ritonavir
- rosuvastatin
- icosapent ethyl
- whey protein
- lamivudine
- nevirapine
- evolocumab
- valsartan
- lopinavir
- alirocumab
- crocus
- acetylsalicylic acid
- cellulose
- inclisiran
- zidovudine
- cilostazol
- dapagliflozin
- soybean
- psyllium
- nattokinase
- +5 more
Phase 3 trials (64)
- colloidal silver
- canosimibe
- olaparib
- fimasartan
- candesartan
- chlorthalidone
- conjugated equine estrogens
- lapaquistat
- progesterone
- diltiazem
- dlbs1449
- dunaliella
- dw-0929
- evacetrapib
- garlic
- insulin glargine
- glimepiride
- acarbose
- Hyzetimibe
- insulin human
- hydralazine
- insulin detemir
- irbesartan
- k-877
- lifibrol
- mipomersen
- pevonedistat
- anacetrapib
- repaglinide
- plantago ovata
- +34 more
Phase 2 trials (50)
- aem-28
- cat 2003
- cat-2054
- cinnamon
- bococizumab
- alpha-lipoic acid
- Diiodothyropropionic acid
- dw-3102
- gemcabene
- eprotirome
- ly3015014
- ly-518674
- mb07811
- md-0727
- mk6213
- nigella sativa
- beta-glucans
- ppd10558
- sch 900271
- secoisolariciresinol
- sevelamer
- ta-8995
- tipelukast
- conjugated linoleic acid
- ramipril
- bean
- calcium propionate
- l-epigallocatechin
- evinacumab
- betahistine mesilate
- +20 more
Phase 1 trials (44)
- retinoic acid
- hyodeoxycholic acid
- aln-pcs02
- beetroot juice
- bibr 1017 bs
- bifidobacterium animalis
- bms-844421
- bms-852927
- linseed oil
- tacrolimus
- hyaluronidase (human recombinant)
- lgt209
- pf-05335810
- pf-06815345
- aluminum hydroxide
- pro-040201
- semaglutide
- sirolimus
- spc4955
- spc5001
- fluconazole
- echium oil
- stearic acid
- coptis chinesis
- clopidogrel
- raltegravir
- affitope ad04
- affitope ad06
- b-cryptoxanthin
- ilex kudingcha
- +14 more
Other trials (65)
- mannitol
- maltodextrin
- vitamin d3
- procaine benzylpenicillin
- chixiangshen tongxin
- egg
- fiber
- gemfibrozil
- grapefruit juice
- tenofovir
- gw-501516
- gw590735
- Hesperedin
- kefir
- cow milk
- sunflower oil
- ubiquinol
- strawberry
- alpha-galacto-oligosaccharides
- apple
- artichoke leaf extract
- autologous microbiome
- bergamot oil
- potato
- brazil nut
- cardichol
- chokeberry extract
- citrus limonoid
- creatine
- iqp-as-118
- +35 more
Organizations
Organization Involved with Phase 4 Indications (105)
- Regeneron
- Daiichi Sankyo
- Amgen
- Servier
- Astellas
- Kowa
- Schering-Plough
- AstraZeneca
- Eli Lilly
- Genzyme
- Sanofi
- Shionogi
- Novartis
- Dong-A Pharmaceutical
- GlaxoSmithKline
- JW Pharmaceutical
- Kuhnil Pharmaceutical Co., Ltd.
- Nang Kuang Pharmaceutical Co., Ltd.
- Provident Clinical Research
- Boehringer Ingelheim
- Chong Kun Dang Pharmaceutical
- Otsuka
- Atlanta Research and Education Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Roma La Sapienza
- Beijing Anzhen Hospital
- Aarhus University
- Abant Izzet Baysal University
- Medical University of Graz
- Birjand University of Medical Sciences
- +75 more
Organization Involved with Phase 3 Indications (76)
- Karo Bio AB
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Ache Laboratorios Farmaceuticos S.A.
- Takeda
- The Medicines Company
- Amryt Research Limited
- Esperion Therapeutics
- Hanlim Pharm. Co., Ltd.
- Innovent Biologics (Suzhou) Co. Ltd.
- Ionis Pharmaceuticals, Inc.
- Kastle Therapeutics, LLC
- Kos Pharmaceuticals
- Madaus Inc
- Orient Europharma Co., Ltd.
- Orient Pharma Co., Ltd.
- Pronova BioPharma
- Alvogen
- Daewon Pharmaceutical Co., Ltd.
- IlDong Pharmaceutical Co Ltd
- Rottapharm
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- National Eye Institute (NEI)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute on Aging (NIA)
- University of Pennsylvania
- Central South University
- Baylor University
- Tzu Chi University
- +46 more
Organization Involved with Phase 2 Indications (85)
- Furiex
- Ligand Pharmaceuticals
- Metabasis
- Ironwood Pharmaceuticals
- MediciNova
- Abionyx
- Cumberland Pharmaceuticals
- Danone Research
- Gemphire Therapeutics, Inc.
- Glycemic Index Laboratories, Inc
- Hengrui Therapeutics, Inc.
- HighTide Biopharma Pty Ltd
- LipimetiX Development, LLC
- Manipal Acunova Ltd.
- Medical Research Laboratories International
- OBEcure Ltd.
- UAS Labs LLC
- Valbiotis
- Viking Therapeutics, Inc.
- CymaBay Therapeutics, Inc.
- Forbes Medi-Tech
- Micropharma Limited
- Western Sydney Local Health District
- University of Manitoba
- Azienda Ospedaliera Brotzu
- Bastyr University
- Federal University of Rio Grande do Sul
- Johns Hopkins University
- McMaster University
- National University of Malaysia
- +55 more
Organization Involved with Phase 1 Indications (20)
- Novo Nordisk
- Alnylam Pharmaceuticals
- Arbutus Biopharma Corporation
- Arrowhead Pharmaceuticals
- Halozyme Therapeutics
- Parexel
- Santaris Pharma A/S
- Afexa Life Sciences, Inc.
- Affiris AG
- Shanghai Junshi Bioscience Co.,Ltd.
- German Research Foundation
- Radboud University
- University of Vienna
- British Heart Foundation
- AtheroNova
- Sun Yat-Sen University
- Friedrich Schiller University
- University of Greifswald
- Nuvisan Pharma Services
- Autonomous University of Madrid
Organization Involved with Other Experimental Indications (79)
- AB Biotics, SA
- Unilever
- Direct Plantes
- Good Food Practice AB
- Inner Mongolia Yili Industrial Group Co., Ltd
- Lescuyer Laboratory
- Menarini Group
- Montefarmaco OTC SpA
- Pin Siang Medical Biotechnology Co., Ltd.
- Raisio Group
- Solae, LLC
- European Foundation for the Study of Diabetes
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Center for Research Resources (NCRR)
- National Institute of Allergy and Infectious Diseases (NIAID)
- United States Department of Agriculture
- Maastricht University
- University of Pittsburgh
- Georgetown University
- Gerencia de Atención Primaria, Albacete
- French Cardiology Society
- Iowa State University
- Listen Trial Group
- Mahidol University
- Medical College of Wisconsin
- Positive Trial Group
- University of Florida
- University of Georgia
- University of Milan
- University of Padua
- +49 more